003020 立方制药
已收盘 02-05 15:00:00
资讯
新帖
简况
立方制药(003020)披露全资子公司取得药品注册证书,1月9日股价上涨0.39%
证券之星 · 01-09
立方制药(003020)披露全资子公司取得药品注册证书,1月9日股价上涨0.39%
立方制药(003020.SZ)子公司取得一项药品注册证书
智通财经 · 01-09
立方制药(003020.SZ)子公司取得一项药品注册证书
爱朋医疗:与立方制药共建联合创新中心
证券之星 · 01-09
爱朋医疗:与立方制药共建联合创新中心
立方制药(003020)新增【人脑工程】概念
证券之星 · 01-06
立方制药(003020)新增【人脑工程】概念
每周股票复盘:立方制药(003020)拟3400万元转让美沙拉秦肠溶片MAH权益
证券之星 · 01-03
每周股票复盘:立方制药(003020)拟3400万元转让美沙拉秦肠溶片MAH权益
立方制药(003020)披露2025年中期权益分派实施公告,11月24日股价上涨0.54%
证券之星 · 2025-11-24
立方制药(003020)披露2025年中期权益分派实施公告,11月24日股价上涨0.54%
立方制药(003020.SZ):达格列净二甲双胍缓释片药品注册上市许可申请获受理
智通财经 · 2025-11-21
立方制药(003020.SZ):达格列净二甲双胍缓释片药品注册上市许可申请获受理
立方制药(003020)2025年三季报简析:净利润同比增长1.65%
证券之星 · 2025-10-31
立方制药(003020)2025年三季报简析:净利润同比增长1.65%
立方制药(003020.SZ)发布前三季度业绩,归母净利润1.21亿元,同比增长1.65%
智通财经 · 2025-10-29
立方制药(003020.SZ)发布前三季度业绩,归母净利润1.21亿元,同比增长1.65%
立方制药:9月22日高管戴天鹤减持股份合计10000股
证券之星 · 2025-09-23
立方制药:9月22日高管戴天鹤减持股份合计10000股
立方制药:9月9日高管郑勇减持股份合计2万股
证券之星 · 2025-09-10
立方制药:9月9日高管郑勇减持股份合计2万股
股市必读:立方制药(003020)9月9日收盘跌6.46%,主力净流出3919.76万元
证券之星 · 2025-09-10
股市必读:立方制药(003020)9月9日收盘跌6.46%,主力净流出3919.76万元
股市必读:立方制药(003020)9月4日收盘跌5.3%,主力净流出3701.63万元
证券之星 · 2025-09-05
股市必读:立方制药(003020)9月4日收盘跌5.3%,主力净流出3701.63万元
立方制药:9月1日高管郑勇减持股份合计10000股
证券之星 · 2025-09-02
立方制药:9月1日高管郑勇减持股份合计10000股
股市必读:立方制药9月1日涨停收盘,收盘价36.43元
证券之星 · 2025-09-02
股市必读:立方制药9月1日涨停收盘,收盘价36.43元
A股化学制药板块触底反弹,向日葵涨超17%,多瑞医药涨超13%,华海药业、同和药业均涨9%,华纳药厂、立方制药等涨。
金融界 · 2025-08-29
A股化学制药板块触底反弹,向日葵涨超17%,多瑞医药涨超13%,华海药业、同和药业均涨9%,华纳药厂、立方制药等涨。
股市必读:立方制药(003020)8月27日收盘跌10%,主力净流出1.45亿元
证券之星 · 2025-08-28
股市必读:立方制药(003020)8月27日收盘跌10%,主力净流出1.45亿元
立方制药(003020.SZ)发布上半年业绩,归母净利润9022.71万元,增长16.53%
智通财经 · 2025-08-25
立方制药(003020.SZ)发布上半年业绩,归母净利润9022.71万元,增长16.53%
股市必读:立方制药(003020)8月21日收盘跌6.94%,主力净流入2013.38万元
证券之星 · 2025-08-22
股市必读:立方制药(003020)8月21日收盘跌6.94%,主力净流入2013.38万元
化学制药板块震荡走弱,易明医药触及跌停,立方制药、联环药业、华海药业、福元医药、诚意药业等跟跌。
金融界 · 2025-08-21
化学制药板块震荡走弱,易明医药触及跌停,立方制药、联环药业、华海药业、福元医药、诚意药业等跟跌。
加载更多
公司概况
公司名称:
合肥立方制药股份有限公司
所属行业:
批发业
上市日期:
2020-12-15
主营业务:
合肥立方制药股份有限公司的主营业务是医药工业及医药商业。公司的主要产品是心脑血管类、精神麻醉类、消化系统类、眼科类、皮肤外用类、其他类。公司连续八年入选“中国化学制药工业企业综合实力百强”,并先后取得“国家火炬计划重点高新技术企业”“安徽省创新型企业”“中国医药工业最具投资价值企业”“皖美品牌示范企业”“安徽省专精特新冠军企业”“合肥市知识产权示范企业”等荣誉。
发行价格:
23.13
{"stockData":{"symbol":"003020","market":"SZ","secType":"STK","nameCN":"立方制药","latestPrice":26.51,"timestamp":1770275010000,"preClose":26.31,"halted":0,"volume":1778405,"delay":0,"changeRate":0.0076,"floatShares":138000000,"shares":190000000,"eps":0.8548,"marketStatus":"已收盘","change":0.2,"latestTime":"02-05 15:00:00","open":26.31,"high":26.9,"low":26.31,"amount":47499800,"amplitude":0.0224,"askPrice":26.52,"askSize":5,"bidPrice":26.51,"bidSize":63,"shortable":0,"etf":0,"ttmEps":0.8548,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770341400000},"marketStatusCode":5,"adr":0,"adjPreClose":26.31,"symbolType":"stock","openAndCloseTimeList":[[1770255000000,1770262200000],[1770267600000,1770274800000]],"highLimit":28.94,"lowLimit":23.68,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":190182182,"isCdr":false,"pbRate":2.78,"roa":"--","peRate":31.013102,"roe":"6.79%","epsLYR":0.84,"committee":-0.266491,"marketValue":5042000000,"turnoverRate":0.0129,"status":0,"floatMarketCap":3651000000},"requestUrl":"/m/hq/s/003020","defaultTab":"news","newsList":[{"id":"2602723443","title":"立方制药(003020)披露全资子公司取得药品注册证书,1月9日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602723443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602723443?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:49","pubTimestamp":1767970152,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,立方制药报收于27.98元,较前一交易日上涨0.39%,最新总市值为53.21亿元。该股当日开盘27.77元,最高27.98元,最低27.32元,成交额达1.14亿元,换手率为3.0%。近日,合肥立方制药股份有限公司全资子公司合肥诚志生物制药有限公司收到国家药品监督管理局核准签发的洛索洛芬钠口服溶液《药品注册证书》。洛索洛芬钠用于类风湿关节炎、骨性关节炎、术后镇痛等多种炎症和疼痛症状。此次获批将丰富公司产品线,提升市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2602732912","title":"立方制药(003020.SZ)子公司取得一项药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2602732912","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602732912?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:29","pubTimestamp":1767950951,"startTime":"0","endTime":"0","summary":"智通财经APP讯,立方制药(003020.SZ)公告,公司全资子公司合肥诚志生物制药有限公司(“诚志生物”)收到国家药品监督管理局核准签发的洛索洛芬钠口服溶液《药品注册证书》。洛索洛芬钠是一种苯丙酸类非甾体抗炎药,具有较好的镇痛、消炎、解热作用,尤其是镇痛作用较强。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"立方制药(003020.SZ)子公司取得一项药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2602456143","title":"爱朋医疗:与立方制药共建联合创新中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2602456143","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602456143?lang=zh_cn&edition=full","pubTime":"2026-01-09 11:33","pubTimestamp":1767929609,"startTime":"0","endTime":"0","summary":"ADHD的治疗以药物治疗、心理治疗和行为训练为主。立方制药的片仿制药“立优加”今年9月正式宣布上市,成为国内首个该品种仿制药。公司于2025年11月4日与立方制药签署了战略合作框架协议,将共建联合创新中心,联合开展AI、脑机接口与药物疗效评价研究。目前双方合作正在逐步推进中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900015031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0251","BK0250","300753"],"gpt_icon":0},{"id":"2601892663","title":"立方制药(003020)新增【人脑工程】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2601892663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601892663?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:30","pubTimestamp":1767702620,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,1月6日立方制药新增概念。该公司关联的其它概念板块还包括:医美概念、创新药、肝炎概念。立方制药主营业务:药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600039241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2600067531","title":"每周股票复盘:立方制药(003020)拟3400万元转让美沙拉秦肠溶片MAH权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2600067531","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600067531?lang=zh_cn&edition=full","pubTime":"2026-01-03 02:38","pubTimestamp":1767379091,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:立方制药拟以3,400.00万元转让美沙拉秦肠溶片药品上市许可持有人及相关权益。公司公告汇总第六届董事会第三次会议审议通过《关于签署〈药品上市许可持有人转让合同〉的议案》,同意以3,400万元(含税)向葵花药业集团佳木斯鹿灵制药有限公司转让美沙拉秦肠溶片药品上市许可持有人及相关权益,表决结果为同意8票、反对0票、弃权0票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2585463389","title":"立方制药(003020)披露2025年中期权益分派实施公告,11月24日股价上涨0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585463389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585463389?lang=zh_cn&edition=full","pubTime":"2025-11-24 18:00","pubTimestamp":1763978459,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘,立方制药报收于27.82元,较前一交易日上涨0.54%,最新总市值为52.91亿元。该股当日开盘27.69元,最高27.93元,最低27.52元,成交额达5595.2万元,换手率为1.46%。公司近日发布《2025年中期权益分派实施公告》,宣布以现有总股本190,182,182股为基数,向全体股东每10股派发现金红利2.00元(含税),合计派发现金红利38,036,436.40元(含税)。本次权益分派不送红股,不以资本公积转增股本。股权登记日为2025年11月27日,除权除息日为2025年11月28日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400023641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2585148051","title":"立方制药(003020.SZ):达格列净二甲双胍缓释片药品注册上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2585148051","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585148051?lang=zh_cn&edition=full","pubTime":"2025-11-21 20:46","pubTimestamp":1763729198,"startTime":"0","endTime":"0","summary":"智通财经APP讯,立方制药 发布公告,近日,公司收到国家药品监督管理局下发的达格列净二甲双胍缓释片、达格列净二甲双胍缓释片及达格列净二甲双胍缓释片药品注册上市许可申请《受理通知书》。据悉,达格列净二甲双胍缓释片是一种固定剂量复方制剂,由钠-葡萄糖协同转运蛋白 2抑制剂达格列净和双胍类药物盐酸二甲双胍组成,结合了两种作用机制不同但相互协同作用的降糖药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"立方制药(003020.SZ):达格列净二甲双胍缓释片药品注册上市许可申请获受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2579101458","title":"立方制药(003020)2025年三季报简析:净利润同比增长1.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579101458","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579101458?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:46","pubTimestamp":1761864398,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期立方制药发布2025年三季报。根据财报显示,立方制药净利润同比增长1.65%。截至本报告期末,公司营业总收入10.81亿元,同比下降3.95%,归母净利润1.21亿元,同比上升1.65%。按单季度数据看,第三季度营业总收入3.48亿元,同比下降2.12%,第三季度归母净利润3071.45万元,同比下降26.08%。去年的净利率为10.04%,算上全部成本后,公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100009766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020"],"gpt_icon":0},{"id":"2579922053","title":"立方制药(003020.SZ)发布前三季度业绩,归母净利润1.21亿元,同比增长1.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579922053","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579922053?lang=zh_cn&edition=full","pubTime":"2025-10-29 16:46","pubTimestamp":1761727619,"startTime":"0","endTime":"0","summary":"智通财经APP讯,立方制药(003020.SZ)发布2025年三季度报告,前三季度,公司实现营业收入10.81亿元,同比下降3.95%。归属于上市公司股东的净利润1.21亿元,同比增长1.65%。归属于上市公司股东的扣除非经常性损益的净利润8935.46万元,同比下降20.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362005.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003020"],"gpt_icon":0},{"id":"2569829713","title":"立方制药:9月22日高管戴天鹤减持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2569829713","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569829713?lang=zh_cn&edition=full","pubTime":"2025-09-23 21:02","pubTimestamp":1758632546,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月23日市场公开信息、上市公司公告及交易所披露数据整理,立方制药(003020)最新董监高及相关人员股份变动情况:2025年9月22日公司高管戴天鹤共减持公司股份1.0万股,占公司总股本为0.0053%。变动期间公司股价下跌0.56%,9月22日当日收盘报28.28元。立方制药近半年内的董监高及核心技术人员增减持详情如下:立方制药的高管列表及最新持股情况如下:该股最近90天内共有2家机构给出评级,买入评级2家。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300034473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2566601475","title":"立方制药:9月9日高管郑勇减持股份合计2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2566601475","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566601475?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:02","pubTimestamp":1757509361,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月10日市场公开信息、上市公司公告及交易所披露数据整理,立方制药(003020)最新董监高及相关人员股份变动情况:2025年9月9日公司高管郑勇共减持公司股份2.0万股,占公司总股本为0.0105%。变动期间公司股价下跌6.46%,9月9日当日收盘报29.39元。立方制药近半年内的董监高及核心技术人员增减持详情如下:立方制药的高管列表及最新持股情况如下:该股最近90天内共有1家机构给出评级,买入评级1家。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000036341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2566614272","title":"股市必读:立方制药(003020)9月9日收盘跌6.46%,主力净流出3919.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566614272","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566614272?lang=zh_cn&edition=full","pubTime":"2025-09-10 01:27","pubTimestamp":1757438830,"startTime":"0","endTime":"0","summary":"截至2025年9月9日收盘,立方制药报收于29.39元,下跌6.46%,换手率7.24%,成交量9.97万手,成交额3.0亿元。当日关注点来自交易信息汇总:立方制药9月9日收盘报29.39元,跌6.46%,当日主力资金净流出3919.76万元,散户资金净流入5357.0万元。该股已连续2日下跌,近5个交易日中有2日跌幅超5%。前10个交易日主力资金累计净流出1.98亿元,股价累计下跌17.26%。资金流向9月9日主力资金净流出3919.76万元,游资资金净流出1437.23万元,散户资金净流入5357.0万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000001218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2565009301","title":"股市必读:立方制药(003020)9月4日收盘跌5.3%,主力净流出3701.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565009301","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565009301?lang=zh_cn&edition=full","pubTime":"2025-09-05 01:45","pubTimestamp":1757007916,"startTime":"0","endTime":"0","summary":"截至2025年9月4日收盘,立方制药报收于31.98元,下跌5.3%,换手率6.66%,成交量9.18万手,成交额3.03亿元。该股已连续3日下跌。前10个交易日主力资金累计净流出2.11亿元,股价累计下跌11.06%。9月4日主力资金净流出3701.63万元,游资资金净流出890.52万元,散户资金净流入4592.15万元。该股最近90天内共有1家机构给出评级,买入评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500001192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2564626800","title":"立方制药:9月1日高管郑勇减持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564626800","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564626800?lang=zh_cn&edition=full","pubTime":"2025-09-02 21:03","pubTimestamp":1756818195,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月2日市场公开信息、上市公司公告及交易所披露数据整理,立方制药(003020)最新董监高及相关人员股份变动情况:2025年9月1日公司高管郑勇共减持公司股份1.0万股,占公司总股本为0.0053%。变动期间公司股价上涨9.99%,9月1日当日收盘报36.43元。立方制药近半年内的董监高及核心技术人员增减持详情如下:立方制药的高管列表及最新持股情况如下:该股最近90天内共有1家机构给出评级,买入评级1家。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200037857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2564849932","title":"股市必读:立方制药9月1日涨停收盘,收盘价36.43元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564849932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564849932?lang=zh_cn&edition=full","pubTime":"2025-09-02 01:15","pubTimestamp":1756746919,"startTime":"0","endTime":"0","summary":"截至2025年9月1日收盘,立方制药报收于36.43元,上涨9.99%,涨停,换手率14.18%,成交量19.53万手,成交额6.95亿元。来自交易信息汇总:9月1日主力资金净流入4906.06万元,显示主力积极介入。交易信息汇总立方制药9月1日涨停收盘,收盘价36.43元。该股于13点47分涨停,未打开涨停,截止收盘封单资金为9792.99万元,占其流通市值1.95%。资金流向方面,9月1日主力资金净流入4906.06万元;游资资金净流出1837.32万元;散户资金净流出3068.74万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200000993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2563209143","title":"A股化学制药板块触底反弹,向日葵涨超17%,多瑞医药涨超13%,华海药业、同和药业均涨9%,华纳药厂、立方制药等涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2563209143","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563209143?lang=zh_cn&edition=full","pubTime":"2025-08-29 10:26","pubTimestamp":1756434388,"startTime":"0","endTime":"0","summary":"A股化学制药板块触底反弹,向日葵涨超17%,多瑞医药涨超13%,华海药业、同和药业均涨9%,华纳药厂、立方制药等涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/29102652792123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0070","BK0156","159982","BK0012","01477","003020","BK1574","300111","BK1191","399300","BK0188","BK0201","688799","301075","600521","BK0028","BK0054","BK0185","300636","BK0250","BK0239"],"gpt_icon":0},{"id":"2562729385","title":"股市必读:立方制药(003020)8月27日收盘跌10%,主力净流出1.45亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562729385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562729385?lang=zh_cn&edition=full","pubTime":"2025-08-28 00:58","pubTimestamp":1756313893,"startTime":"0","endTime":"0","summary":"截至2025年8月27日收盘,立方制药报收于32.31元,下跌10.0%,换手率13.82%,成交量19.03万手,成交额6.42亿元。当日关注点交易信息汇总:立方制药8月27日收盘报32.31元,跌10%,并因日跌幅偏离值达到7%而登上龙虎榜。根据收盘数据统计,该股已连续2日下跌,近5个交易日中有3日跌幅超5%。前10个交易日资金流向情况显示,主力资金累计净流出3346.29万元,但股价累计上涨12.24%。该股最近90天内共有1家机构给出评级,为买入评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800001186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2562248704","title":"立方制药(003020.SZ)发布上半年业绩,归母净利润9022.71万元,增长16.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562248704","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562248704?lang=zh_cn&edition=full","pubTime":"2025-08-25 18:35","pubTimestamp":1756118138,"startTime":"0","endTime":"0","summary":"智通财经APP讯,立方制药(003020.SZ)发布2025年半年度报告,该公司营业收入为7.32亿元,同比减少4.80%。归属于上市公司股东的净利润为9022.71万元,同比增长16.53%。归属于上市公司股东的扣除非经常性损益的净利润为6622.09万元,同比减少9.68%。基本每股收益为0.47元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"立方制药(003020.SZ)发布上半年业绩,归母净利润9022.71万元,增长16.53%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003020"],"gpt_icon":0},{"id":"2561180864","title":"股市必读:立方制药(003020)8月21日收盘跌6.94%,主力净流入2013.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561180864","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561180864?lang=zh_cn&edition=full","pubTime":"2025-08-22 02:41","pubTimestamp":1755801671,"startTime":"0","endTime":"0","summary":"截至2025年8月21日收盘,立方制药报收于36.07元,下跌6.94%,换手率11.71%,成交量16.13万手,成交额5.8亿元。交易信息汇总8月21日立方制药收盘报36.07元,跌6.94%,当日成交1613.2万元。前10个交易日资金流向情况:主力资金累计净流入9805.15万元,股价累计上涨29.95%。该股最近90天内共有1家机构给出评级,买入评级1家。资金流向8月21日主力资金净流入2013.38万元;游资资金净流入1545.22万元;散户资金净流出3558.6万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200002110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2561143146","title":"化学制药板块震荡走弱,易明医药触及跌停,立方制药、联环药业、华海药业、福元医药、诚意药业等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2561143146","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561143146?lang=zh_cn&edition=full","pubTime":"2025-08-21 10:09","pubTimestamp":1755742175,"startTime":"0","endTime":"0","summary":"化学制药板块震荡走弱,易明医药触及跌停,立方制药、联环药业、华海药业、福元医药、诚意药业等跟跌。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/21100952581769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","002826","BK1574","BK1191","003020","BK0250","603811","BK0033","600513","BK0185","01477","BK0070","BK0056","BK0028","601089","BK0012","BK0201","BK0188","600521"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770287640861,"stockEarnings":[{"period":"1week","weight":-0.0284},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0885},{"period":"6month","weight":-0.0223},{"period":"1year","weight":0.4864},{"period":"ytd","weight":0.0166}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":0.0196},{"period":"3month","weight":0.0236},{"period":"6month","weight":0.1285},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0336}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"合肥立方制药股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"18105人(较上一季度减少88.68%)","perCapita":"7606股","listingDate":"2020-12-15","address":"安徽省合肥市蜀山区长江西路669号立方厂区","registeredCapital":"19018万元","survey":" 合肥立方制药股份有限公司的主营业务是医药工业及医药商业。公司的主要产品是心脑血管类、精神麻醉类、消化系统类、眼科类、皮肤外用类、其他类。公司连续八年入选“中国化学制药工业企业综合实力百强”,并先后取得“国家火炬计划重点高新技术企业”“安徽省创新型企业”“中国医药工业最具投资价值企业”“皖美品牌示范企业”“安徽省专精特新冠军企业”“合肥市知识产权示范企业”等荣誉。","listedPrice":23.13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"立方制药(003020)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供立方制药(003020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"立方制药,003020,立方制药股票,立方制药股票老虎,立方制药股票老虎国际,立方制药行情,立方制药股票行情,立方制药股价,立方制药股市,立方制药股票价格,立方制药股票交易,立方制药股票购买,立方制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"立方制药(003020)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供立方制药(003020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}